Performance of ICD‐10‐CM diagnosis codes for identifying children with Sickle Cell Anemia
dc.contributor.author | Reeves, Sarah L. | |
dc.contributor.author | Madden, Brian | |
dc.contributor.author | Wu, Meng | |
dc.contributor.author | Miller, Lauren S. | |
dc.contributor.author | Anders, David | |
dc.contributor.author | Caggana, Michele | |
dc.contributor.author | Cogan, Lindsay W. | |
dc.contributor.author | Kleyn, Mary | |
dc.contributor.author | Hurden, Isabel | |
dc.contributor.author | Freed, Gary L. | |
dc.contributor.author | Dombkowski, Kevin J. | |
dc.date.accessioned | 2020-04-02T18:38:23Z | |
dc.date.available | WITHHELD_13_MONTHS | |
dc.date.available | 2020-04-02T18:38:23Z | |
dc.date.issued | 2020-04 | |
dc.identifier.citation | Reeves, Sarah L.; Madden, Brian; Wu, Meng; Miller, Lauren S.; Anders, David; Caggana, Michele; Cogan, Lindsay W.; Kleyn, Mary; Hurden, Isabel; Freed, Gary L.; Dombkowski, Kevin J. (2020). "Performance of ICD‐10‐CM diagnosis codes for identifying children with Sickle Cell Anemia." Health Services Research 55(2): 310-317. | |
dc.identifier.issn | 0017-9124 | |
dc.identifier.issn | 1475-6773 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/154614 | |
dc.description.abstract | ObjectiveTo develop, test, and validate the performance of ICD‐10‐CM claims‐based case definitions for identifying children with sickle cell anemia (SCA).Data SourcesMedicaid administrative claims (2016) for children <18 years with potential SCA (any D57x diagnosis code) and newborn screening records from Michigan and New York State.Study DesignThis study is a secondary data analysis.Data Collection/Extraction MethodsUsing specific SCA‐related (D5700, D5701, and D5702) and nonspecific (D571) diagnosis codes, 23 SCA case definitions were applied to Michigan Medicaid claims (2016) to identify children with SCA. Measures of performance (sensitivity, specificity, area under the ROC curve) were calculated using newborn screening results as the gold standard. A parallel analysis was conducted using New York State Medicaid claims and newborn screening data.Principal FindingsIn Michigan Medicaid, 1597 children had ≥1 D57x claim; 280 (18 percent) were diagnosed with SCA. Measures of performance varied, with sensitivities from 0.02 to 0.97 and specificities from 0.88 to 1.0. The case definition of ≥1 outpatient visit with a SCA‐related or D571 code had the highest area under the ROC curve, with a sensitivity of 95 percent and specificity of 92 percent. The same definition also had the highest performance in New York Medicaid (n = 2454), with a sensitivity of 94 percent and specificity of 86 percent.ConclusionsChildren with SCA can be accurately identified in administrative claims using this straightforward case definition. This methodology can be used to monitor trends and use of health services after transition to ICD‐10‐CM. | |
dc.publisher | NIHR Journals Library | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | sickle cell anemia | |
dc.subject.other | administrative claims | |
dc.subject.other | ICD‐10‐CM | |
dc.title | Performance of ICD‐10‐CM diagnosis codes for identifying children with Sickle Cell Anemia | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Public Health | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/154614/1/hesr13257.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/154614/2/hesr13257_am.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/154614/3/hesr13257-sup-0001-Authormatrix.pdf | |
dc.identifier.doi | 10.1111/1475-6773.13257 | |
dc.identifier.source | Health Services Research | |
dc.identifier.citedreference | Ronald LA, Ling DI, FitzGerald JM, et al. Validated methods for identifying tuberculosis patients in health administrative databases: systematic review. Int J Tuberc Lung Dis. 2017; 21 ( 5 ): 517 ‐ 522. | |
dc.identifier.citedreference | DeBaun MR, Strunk RC. The intersection between asthma and acute chest syndrome in children with sickle‐cell anaemia. Lancet. 2016; 387 ( 10037 ): 2545 ‐ 2553. | |
dc.identifier.citedreference | Boulet SL, Yanni EA, Creary MS, Olney RS. Health status and healthcare use in a national sample of children with sickle cell disease. Am J Prev Med. 2010; 38 ( 4 Suppl ): S528 ‐ 535. | |
dc.identifier.citedreference | Jackson T, Krauss MJ, DeBaun MR, Strunk RC, Arbeláez AM. Vitamin‐D Deficiency and Comorbidities in Children with Sickle Cell Anemia. Pediatr Hematol Oncol. 2012; 29 ( 3 ): 261 ‐ 266. | |
dc.identifier.citedreference | Raphael JL, Dietrich CL, Whitmire D, Mahoney DH, Mueller BU, Giardino AP. Healthcare utilization and expenditures for low income children with sickle cell disease. Pediatr Blood Cancer. 2009; 52 ( 2 ): 263 ‐ 267. | |
dc.identifier.citedreference | Grosse SD, Boulet SL, Amendah DD, Oyeku SO. Administrative data sets and health services research on hemoglobinopathies: a review of the literature. Am J Prev Med. 2010; 38 ( 4 Supplement ): S557 ‐ S567. | |
dc.identifier.citedreference | Amed S, Vanderloo SE, Metzger D, et al. Validation of diabetes case definitions using administrative claims data. Diabet Med. 2011; 28 ( 4 ): 424 ‐ 427. | |
dc.identifier.citedreference | Dart AB, Martens PJ, Sellers EA, Brownell MD, Rigatto C, Dean HJ. Validation of a pediatric diabetes case definition using administrative health data in manitoba. Canada. Diabetes Care. 2011; 34 ( 4 ): 898 ‐ 903. | |
dc.identifier.citedreference | Rezaie A, Quan H, Fedorak RN, Panaccione R, Hilsden RJ. Development and validation of an administrative case definition for inflammatory bowel diseases. Can J Gastroenterol. 2012; 26 ( 10 ): 711 ‐ 717. | |
dc.identifier.citedreference | Dombkowski KJ, Lamarand K, Dong S, Perng W, Clark SJ. Using Medicaid claims to identify children with asthma. J Public Health Manag Pract. 2012; 18 ( 3 ): 196 ‐ 203. | |
dc.identifier.citedreference | Michalik DE, Taylor BW, Panepinto JA. Identification and validation of a sickle cell disease cohort within electronic health records. Acad Pediatr. 2017; 17 ( 3 ): 283 ‐ 287. | |
dc.identifier.citedreference | Snyder AB, Lane PA, Zhou M, Paulukonis ST, Hulihan MM. The accuracy of hospital ICD‐9‐CM codes for determining Sickle Cell Disease genotype. Journal of rare diseases research & treatment. 2017; 2 ( 4 ): 39 ‐ 45. | |
dc.identifier.citedreference | Khera R, Dorsey KB, Krumholz HM. Transition to the ICD‐10 in the United States: an emerging data chasm. JAMA. 2018; 320 ( 2 ): 133 ‐ 134. | |
dc.identifier.citedreference | Centers for Medicare and Medicaid Services. Clarifying Questions and Answers Related to the July 6, 2015, CMS/AMA Joint Announcement and Guidance Regarding ICD‐10 Flexibilities. https://www.cms.gov/Medicare/Coding/ICD10/Clarifying-Questions-and-Answers-Related-to-the-July-6-2015-CMS-AMA-Joint-Announcement.pdf. Accessed September 3, 2019. | |
dc.identifier.citedreference | NCQA. HEDIS & Performance Measurement. 2017. http://www.ncqa.org/hedis-quality-measurement. Accessed May 02, 2018. | |
dc.identifier.citedreference | Kuhlthau K, Ferris TG, Beal AC, Gortmaker SL, Perrin JM. Who cares for medicaid‐enrolled children with chronic conditions? Pediatrics. 2001; 108 ( 4 ): 906 ‐ 912. | |
dc.identifier.citedreference | Perrin JM, Kuhlthau KA, Gortmaker SL, Beal AC, Ferris TG. Generalist and subspecialist care for children with chronic conditions. Ambul Pediatr. 2002; 2 ( 6 ): 462 ‐ 469. | |
dc.identifier.citedreference | Korzeniewski SJ, Grigorescu V, Copeland G, et al. Methodological innovations in data gathering: newborn screening linkage with live births records, Michigan, 1/2007‐3/2008. Matern Child Health J. 2010; 14 ( 3 ): 360 ‐ 364. | |
dc.identifier.citedreference | Shapiro DE. The interpretation of diagnostic tests. Stat Methods Med Res. 1999; 8 ( 2 ): 113 ‐ 134. | |
dc.identifier.citedreference | Anders DG, Tang F, Ledneva T, et al. Hydroxyurea use in young children with sickle cell anemia in New York State. Am J Prev Med. 2016; 51 ( 1 Suppl 1 ): S31 ‐ 38. | |
dc.identifier.citedreference | Eisenbrown K, Nimmer M, Brousseau DC. The accuracy of using ICD‐9‐CM codes to determine genotype and fever status of patients with sickle cell disease. Pediatr Blood Cancer. 2015; 62 ( 5 ): 924 ‐ 925. | |
dc.identifier.citedreference | Amendah DD, Mvundura M, Kavanagh PL, Sprinz PG, Grosse SD. Sickle cell disease‐related pediatric medical expenditures in the U.S. Am J Prev Med. 2010; 38 ( 4 Suppl ): S550 ‐ 556. | |
dc.identifier.citedreference | Hulihan MM, Feuchtbaum L, Jordan L, et al. State‐based surveillance for selected hemoglobinopathies. Genet Med. 2015; 17 ( 2 ): 125 ‐ 130. | |
dc.identifier.citedreference | Paulukonis ST, Harris WT, Coates TD, et al. Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH). Pediatr Blood Cancer. 2014; 61 ( 12 ): 2271 ‐ 2276. | |
dc.identifier.citedreference | Reeves S, Garcia E, Kleyn M, et al. Identifying sickle cell disease cases using administrative claims. Acad Pediatr. 2014; 14 ( 5 Suppl ): S61 ‐ 67. | |
dc.identifier.citedreference | Snyder AB, Lane PA, Zhou M, Paulukonis ST, Hulihan MM. The accuracy of hospital ICD‐9‐CM codes for determining Sickle Cell Disease genotype. J Rare Dis Res Treat. 2017; 2 ( 4 ): 39 ‐ 45. | |
dc.identifier.citedreference | Freeman JL, Zhang D, Freeman DH, Goodwin JS. An approach to identifying incident breast cancer cases using Medicare claims data. J Clin Epidemiol. 2000; 53 ( 6 ): 605 ‐ 614. | |
dc.identifier.citedreference | Yu O, Nelson JC, Bounds L, Jackson LA. Classification algorithms to improve the accuracy of identifying patients hospitalized with community‐acquired pneumonia using administrative data. Epidemiol Infect. 2011; 139 ( 9 ): 1296 ‐ 1306. | |
dc.identifier.citedreference | Aronsky D, Haug PJ, Lagor C, Dean NC. Accuracy of administrative data for identifying patients with pneumonia. Am J Med Qual. 2005; 20 ( 6 ): 319 ‐ 328. | |
dc.identifier.citedreference | Reeves SL, Jary HK, Gondhi JP, Kleyn M, Wagner AL, Dombkowski KJ. Pneumococcal vaccination coverage among children with sickle cell anemia, sickle cell trait, and normal hemoglobin. Pediatr Blood Cancer. 2018; e27282. | |
dc.identifier.citedreference | Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010; 38 ( 4 Suppl ): S512 ‐ 521. | |
dc.identifier.citedreference | National Heart Lung and Blood Institute. Evidence‐Based Management of Sickle Cell Disease: Expert Panel Report. 2014. https://www.nhlbi.nih.gov/health-pro/guidelines/sickle-cell-disease-guidelines. Accessed August 21, 2018. | |
dc.identifier.citedreference | National Heart Lung and Blood Institute. Sickle Cell Disease. 2017. https://www.nhlbi.nih.gov/health/health-topics/topics/sca. Accessed February 22, 2018. | |
dc.identifier.citedreference | Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991; 325 ( 1 ): 11 ‐ 16. | |
dc.identifier.citedreference | Cherry MGGJ, Osipenko L, Osipenko L, et al. The Clinical Effectiveness and Cost‐Effectiveness of Primary Stroke Prevention in Children with Sickle Cell Disease: A Systematic Review and Economic Evaluation. Volume 16. 43. Southampton, UK: NIHR Journals Library; 2012. | |
dc.identifier.citedreference | Overturf GD, Powars D, Baraff LJ. Bacterial meningitis and septicemia in sickle cell disease. Am J Dis Child. 1977; 131 ( 7 ): 784 ‐ 787. | |
dc.identifier.citedreference | Reeves S, Garcia E, Kleyn M, et al. Identifying Sickle Cell Disease Cases Using Administrative Claims. Acad Pediatr. 2014; 14 ( 5 Supplement ): S61 ‐ S67. | |
dc.identifier.citedreference | Graves JK, Hodge C, Depression JE. Depression, Anxiety, and Quality of Life In Children and Adolescents With Sickle Cell Disease. Pediatr Nurs. 2016; 42 ( 3 ): 113 ‐ 119, 144. | |
dc.identifier.citedreference | Graves JK, Jacob E. Pain, coping, and sleep in children and adolescents with sickle cell disease. J Child Adolesc Psychiatr Nurs. 2014; 27 ( 3 ): 109 ‐ 120. | |
dc.identifier.citedreference | Jerrell JM, Tripathi A, McIntyre RS. Prevalence and treatment of depression in children and adolescents with sickle cell disease: a retrospective cohort study. Prim Care Companion CNS Disord. 2011; 13 ( 2 ). | |
dc.identifier.citedreference | Jonassaint CR, Jones VL, Leong S, Frierson GM. A systematic review of the association between depression and health care utilization in children and adults with sickle cell disease. Br J Haematol. 2016; 174 ( 1 ): 136 ‐ 147. | |
dc.identifier.citedreference | Midence K, Fuggle P, Davies SC. Psychosocial aspects of sickle cell disease (SCD) in childhood and adolescence: a review. Br J Clin Psychol. 1993; 32 ( Pt 3 ): 271 ‐ 280. | |
dc.identifier.citedreference | Whitten CF, Fischhoff J. Psychosocial effects of sickle cell disease. Arch Intern Med. 1974; 133 ( 4 ): 681 ‐ 689. | |
dc.identifier.citedreference | Yang YM, Cepeda M, Price C, Shah A, Mankad V. Depression in children and adolescents with sickle‐cell disease. Arch Pediatr Adolesc Med. 1994; 148 ( 5 ): 457 ‐ 460. | |
dc.identifier.citedreference | Anim SO, Strunk RC, DeBaun MR. Asthma morbidity and treatment in children with sickle cell disease. Expert Rev Respir Med. 2011; 5 ( 5 ): 635 ‐ 645. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.